This article has Open Peer Review reports available.
Emergency coronary artery bypass grafting using minimized versus standard extracorporeal circulation – a propensity score analysis
© Ried et al.; licensee BioMed Central Ltd. 2013
Received: 20 September 2012
Accepted: 27 March 2013
Published: 2 April 2013
The impact of minimized extracorporeal circulation (MECC) for emergency revascularization remains controversial.
A total of 348 patients underwent emergency CABG with MECC (n=146) or conventional extracorporeal circulation (CECC; n=175) between January 2005 and December 2010. Using propensity score matching after binary logistic regression, 100 patients, who underwent CABG with MECC could be matched with 100 patients, who underwent CABG with CECC. Primary outcome was 30-day mortality.
Unadjusted 30-day mortality was 14.8% in patients with CECC and 6.9% in those with MECC (mean difference −7.9%; p=0.03). The adjusted mean difference (average treatment effect of the treated, ATT) after matching was −1.0% (95% CI −8.6 to 7.6; p=1.0). Intensive care unit stay (adjusted mean difference 1.0; 95% CI −0.2 to 3.2; p=0.70) and hospital stay (adjusted mean difference 1.0; 95% CI −2.0 to 3.6; p=0.40) did not show significant differences between both groups. The adjusted mean difference for postoperative low cardiac output syndrome was −1.1% (95% CI −7.3 to 7.1; p=0.83) without significant differences between CECC and MECC. Postoperative mechanical ventilation time, drain loss, postoperative rethoracotomy, postoperative neurological events, new onset renal replacement therapy and respiratory failure also had insignificant average treatment effects of the treated. In addition, all average treatment effects (ATEs) did not significantly differ between both groups.
Using propensity score estimation and matching, we did not observe significant differences in terms of survival and further outcomes in patients who undergo emergency CABG with CECC or MECC, but our results call for further analysis.
Coronary artery bypass grafting (CABG) with cardiopulmonary bypass support (CPB) as standard perfusion technique remains the treatment of choice for high-grade left main-stem stenosis and triple-vessel coronary artery disease[1, 2]. Several studies compared the impact of minimized versus conventional extracorporeal circuits and found conflicting results. Development and utilization of MECC have been proposed to reduce the adverse effects of CECC during CABG while taking the advantages of standard ECC[3–5]. Various publications have reported that MECC decreases perioperative side effects such as systemic inflammation, coagulation derangement and postoperative complications[6–8], whereas other reports failed to confirm these promising results. Our department has been performing CABG with MECC for more than one decade and we could demonstrate that MECC is a safe alternative for on-pump and off-pump coronary revascularization. Even in high-risk patients MECC using could be successfully applied.
However, emergency patients suffering from an acute coronary syndrome are at high-risk and perioperative mortality is still increased if undergoing CABG with standard ECC. Recent studies reported a survival benefit in this high-risk group of patients by performing beating-heart or off-pump coronary revascularization[13–15]. Nevertheless, application of MECC in patients emergency CABG remains controversial and no evidence suggests using MECC for emergency CABG.
Purpose of the present study was to examine the feasibility and efficacy of minimized ECC use in patients undergoing emergency surgical revascularization. Propensity score matching reduced significant selection bias between both groups and enabled direct comparison.
Patients and study design
From January 2005 to December 2010 a total of 321 consecutive patients who underwent emergency coronary artery bypass graft surgery (CABG) at the University Medical Center Regensburg were studied. The study was approved by the university’s ethics board, the individual patients consent was waived because of the study’s retrospective design and data collection from routine care. Included were only patients with emergency presentation due to acute coronary syndrome (unstable angina, non-ST-segment and ST-segment elevation myocardial infarction, elevated myocardial markers) which prompted isolated CABG within 24 hours after hospital admission. Acute myocardial infarction was diagnosed by conventional 12-channel electrocardiography in addition to myocardial enzymes and confirmed by immediate coronary angiography. All patients were evaluated for percutaneous coronary intervention (PCI). Coronary lesions (left main-stem stenosis, complicated and multiple lesions) were unsuitable for primary PCI. CABG procedures were performed with conventional (CECC) or minimized extracorporeal circulation (MECC) under general anesthesia. Patients with severe aortic regurgitation, a body mass index (BMI) ≥ 35 kg × m-2 and renal end-stage failure were relative contraindications for MECC support. Complete surgical revascularization was the aim in all patients and hybrid procedures were not primarily indicated. Exclusion criteria were as follows: elective CABG, conversion to surgical correction after failed PCI, beating-heart techniques, off-pump revascularization (OPCAB), redo surgery and preoperative renal replacement therapy. All operations were performed by six senior surgeons who are experienced in CABG with conventional as well as minimized extracorporeal circulation.
Patients’ data were collected prospectively in and retrospectively extracted from the institution’s database and from medical records, including demographic, clinical and outcome data. Variables were defined according to the European System of Cardiac Operative Risk Evaluation (EuroSCORE) and perioperative mortality was predicted with the logistic version of this risk stratification model[16, 17]. Serum creatinine (SCr) was measured preoperatively in mg/dL at the day of hospital admission. Postoperative the peak SCr value 24 hours after surgery was analysed. Glomerular filtration rate (GFR) was calculated with the abbreviated Modification of Diet in Renal Disease (MDRD) formula and expressed in mL/min/1.73 m2: MDRD-eGFR = 186.3 × SCr –1.154 × age –0.203. Oliguria was defined as urine output < 500 mL within 24 hours. Postoperative acute kidney injury was defined as a decrease of glomerular filtration rate ≥ 50% or the need of dialysis due to oliguria. The diagnosis of pneumonia was based on clinical presentation, chest X-ray and positive sputum cultures. Postoperative respiratory failure was defined as severe decline of arterial pO2 < 50 mmHg, an increase in pCO2 > 60 mmHg and an increase in respiratory rate > 40/min. Postoperative central neurologic event included transient/prolonged ischemic neurological deficit and stroke.
The primary study endpoint was postoperative mortality defined as death within 30 days after operation. The secondary endpoint was postoperative morbidity during hospitalization, which were as follows: low cardiac output syndrome (LCOS), respiratory failure, prolonged mechanical ventilation, central neurologic event or requirement of renal replacement therapy.
Surgical management and perfusion techniques
Full midline sternotomy was routinely done and all patients were operated on cardiopulmonary bypass by standard cannulation of the ascending aorta and the right atrium (two-stage cannula). Mild hypothermia was applied and complete cardiac arrest was induced using Calafiore’s blood cardioplegia. During conventional cardiopulmonary bypass (CPB) blood was collected in an open cardiotomy reservoir and afterwards transfused back to the patient. At the end of harvesting the left internal mammary artery (LIMA), heparin (350 IE/Kg) was administered to target an activated clotting time (ACT) of ≥ 450 seconds in patients with CECC. The MECC-system (Maquet, Rastatt, Germany) is a fully closed circuit without blood-air contact. The tube set was pre-connected and completely coated with heparin. The prime volume was 500 mL and no heparin was added. For MECC heparin (125 IE/kg) was administered after LIMA preparation targeting an ACT between 250 and 300 seconds because of the reduced artificial surface. Blood was saved only with cell saver. Distal anastomoses were done using 7–0 or 8–0 monofilament sutures. At the end of the operation heparin was antagonized with protamine sulfate.
Anesthesia was maintained with inhalational and intravenous agents. Postoperatively, all patients were transferred to the intensive care unit (ICU) and received standard monitoring and mechanical ventilation.
Statistical analysis was done with Stata 10.1 SE (Stata Corp., College Station, USA). Figures were created either with Stata or SigmaPlot 12.5 (Systat Software Inc., San Jose, USA). Stata’s module psmatch2 was used for propensity score matching and covariate imbalance testing. Continuous variables were first tested for normality with the Shapiro-Wilk test and visually with Quantile-Quantile plots. If normally distributed, they are presented as mean ± standard deviation (SD), otherwise as median with interquartile range (25th and 75th percentile). Student’s t test was used for comparison of two continuous, normally distributed variables, whereas Wilcoxon’s ranksum test was taken for non-normally distributed variables. Categorical data were shown as frequency distributions and were analyzed with Fisher’s exact test for 2 × 2 tables or with the Chi-Square test.
Unadjusted, i.e. before matching, pre- and operative data
68.4 ± 9.74
67.8 ± 8.74
Age group [n; %]
Male gender [n; %]
Logistic EuroSCORE [%, 95% CI]
16.0 (13.4 to 18.2)
12.8 (10.9 to 14.6)
Ejection fraction [%]
50 (40; 64)
56 (45; 70)
172 (165; 176)
172 (166; 176)
82 (73; 93)
80 (70; 90)
Atrial fibrillation, preoperative [n; %]
COPD, preoperative [n; %]
Inhalative β2-Mimetic use [n; %]
Myocardial infarction preoperative [n; %]
Troponin I preoperative [ng/mL)A
5.1 (1.0 to 21)
3.8 (0.4 to 0.7)
Insulin-dependent diabetes [n; %]
Non insulin-dpendent diabetes [n; %]
Diabetic nephropathy [n;%]
Serum creatinine, preoperative [mg ×dL-1]
1.0 (0.8; 1.3)
0.9 (0.8; 1.2)
Estimated GFR < 60 mL × min-1 × 1.73 m-2 [n; %]
No of grafts [n]
2.95 ± 0.88
2.7 ± 0.80
LIMA use [n; %]
Bypass time [min]
96 (69; 119)
74 (54; 93)
Aortic cross clamp time [min]
47 (34; 61)
37 (27; 50)
Before matching the mean PS for MECC use in patients operated with CECC (n=175) was 0.399 ± 0.168 and in those receiving CABG with MECC 0.524 ± 0.156 with an associated standardized difference of 77.1% (95% CI 54 to 99; t test p-value < 0.0001). After matching, the mean PS for MECC use in the matched patients not receiving MECC was 0.471 ± 0.144 and in those receiving MECC was 0.474 ± 0.135 which yielded a standardized difference of 2.1% (95% CI −2.6 to 2.9; p > 0.05 for a two-tailed test).
Covariate imbalance was tested using the standardized difference before and after matching together with the achieved percentage reduction in absolute bias. The standardized difference is the difference of the sample means in the treated and non-treated sub-samples as a percentage of the square root of the average of the sample variances in the treated and non-treated groups.
The average treatment effect for the treated (ATT) answers the question: Is MECC beneficial for those individuals, who were (not randomly) assigned to treatment, i.e. MECC and was estimated with Wilcoxon’s signed rank test for continuous variables or with McNemar’s test for risk differences to account for the paired data structure after matching. We also calculated the average treatment effect that answers the question if MECC is beneficial for those randomly drawn from the overall population. Bootstrapping (400 replications) was used to estimate 95% confidence intervals (CIs) for ATEs. The key notion is ATT≠ATE and they are linked via ATE = N1/N × ATT + N0/N × ATU (N0 denotes the number of non-participants, N1 denotes the number of participants and ATU is the average treatment effect for the non-participants.
Hidden bias was estimated according to Rosenbaum’s sensitivity analysis. We used Stata’s rbounds module for this test.
Unadjusted baseline data before matching were summarized in Table 1. Several pre- and operative data were significantly different between both groups, including ejection fraction, renal function and LIMA use. It may reflect the non-randomized study design. Whereas EF was slightly higher in the MECC group, bypass and cross-clamp time were longer in the CECC group.
Covariate balance testing between unmatched and matched sample
Standardized difference [%]
% reduction |difference|
No of grafts
Cross clamp time
Matching reduced covariate imbalance and improved covariate balance between treatment groups. The median absolute bias before matching was 32.6% and after matching 5.9%.
The unadjusted 30-day mortality was 14.8% (26/175) in the CECC group and 6.9% (10/146) in the MECC group (mean difference −7.9%; p=0.032). After matching, the mean difference was −1.0% (95% CI −8.6 to 7.6; p=1.0) and shows no survival benefit for emergency patients, who were primarily assigned to MECC. If randomly drawn from the overall population, emergency CABG with MECC also does not exert a survival benefit (ATE; -1.5%; 95% CI −8.1 to 5.8; p > 0.05).
Estimated average treatment effects on several outcome variables
30-day mortality [%]
Hospital stay [days]
Low cardiac output [%]
CECC versus MECC
Unadjusted mean difference
Adjusted mean difference after matching of 100 pairs (95% bias corrected CI)
−1.0 (−8.6 to 7.6)
1.0 (−0.21 to 3.24)
1.0 (−2 to 3.6)
−1.1 (−7.3 to 7.1)
Adjusted mean difference with 95% bias corrected CI)
−1.5 (−8.1 to 5.8)E
0.61 (−0.7 to 2.2)E
0.34 (−2.5 to 2.6)E
−1.7 (−7.1 to 6.5)E
Unadjusted in-hospital mortality was 13.7% (24/175) in the CECC group and 5.5% (8/146) in the MECC group (mean difference – 8.8%; p=0.015). The ATE was estimated with −1.1% (95% CI −7.1 to 6.4; p=1.00) and the ATE was estimated with −1.0% (95% CI −8.1 to 3.8).
Secondary outcome measures
ATT (95% CI)
ATE (95% CI)
Drain loss in 24 h [mL]
625 (350; 1100)
600 (350; 1000)
161 (−111 to 464)
164 (−109 to 406)
3.2 (−4.9 to 12.1)
1.5 (−6.2 to 9.3)
Neurological event [%]
4.3 (−1.0 to 1.2)
−4.0 (−8.6 to 2.3)
New onset RRT [%]A
2.1 (−5.8 to 8.2)
2.5 (−3.2 to 8.5)
Respiratory failure [%]
3.2 (−2.4 to 14.9)
1.5 (−4.3 to 14.3)
The frequency of rethoracotomy was almost 10% in both groups and the most common reason was postoperative bleeding (80%) followed by hematoma. Postoperative low cardiac output was treated either with intra-aortic ballon pump (n=2 in the MECC group; n=4 in the CECC group) or with veno-arterial ECMO (n=8 in the CECC group).
Selection bias remains the most challenging analytic problem in observational studies and thus, we conducted a sensitivity analysis using Rosenbaum’s approach. Using Wilcoxon’s signed rank test, the sensitivity analysis showed that our study becomes sensitive to hidden bias at Γ = 1.8 for 30-day mortality, at Γ = 1.5, at Γ = 1.2 and at Γ = 2.5 for low cardiac output syndrome. Because these values are small, we conclude that the study is quite sensitive to hidden bias and therefore further analysis that control for additional biases is warranted.
Emergency CABG should be performed in patients with cardiogenic shock due to left main or severe triple vessel disease and whenever PCI is unlikely to achieve complete revascularization. However, the application of different revascularization techniques to patients undergoing emergency CABG remains controversial. Data on optimal treatment strategies are still lacking and the logistic EuroSCORE as a tool for risk stratification is suggested to overestimate mortality in emergency patients. Emergency procedures are associated with an enhanced perioperative risk, mainly caused by patient’s preoperative condition. Using ECC with cardioplegic arrest may contribute to surgical complications and mortality. Some previous studies reported improved outcome for those patients operated upon beating heart or off-pump[14, 15, 23] with mortality rates comparable to patients operated upon on-pump.
To the best of our knowledge, there are no studies that examine the impact of minimized circuits on outcome after emergent CABG surgery compared to conventional ECC. Propensity score methods are increasingly being used to reduce the impact of treatment-selection bias in the estimation of causal treatment effects in observational studies[25, 26]. We used propensity score matching to estimate the treatment effect of MECC for emergency CABG procedures because the comparison of the unadjusted data showed significant bias. After matching we failed to demonstrate benefits for MECC in terms of survival, ICU and hospital stay, LCOS, postoperative ventilation, new onset renal replacement therapy among several others. Although our primary sample comprised only 321 patients and we achieved a moderate matching efficiency of 69%, the resulting pairs were very comparable with a very low standardized difference of the PS.
The unadjusted data indicate an imbalance in patient selection, i.e. MECC patients had a better EF, a lower number of grafts, a somewhat higher LIMA use and shorter bypass and cross-clamp times. Thus, improved outcome may be expected. A question of concern arose from the overall low LIMA use and it was not possible to address this issue entirely. Analysis of patient records mentioned hemodynamic instability in majority of patients and inappropriateness of vessel diameter or flow in some cases. In the minority of cases, the decision to use LIMA or not, however, was an individual surgeon decision but gives room for improvement.
In non-emergency patients, MECC was shown to exert some benefit in terms of postoperative renal function, transfusion requirement and neurological dysfunction[27, 28]. We failed to show these effects in our matched cohort since new onset RRT and incidence of cerebral event did not differ. We did not specifically address the issue of transfusion requirement because the majority of our patients received multiple anticoagulants before surgery and usually, RBC and plasma transfusions are more frequently seen in this patient group.
However, even advanced statistical methods to adjust imbalance between control and treatment in observational studies cannot compensate the current lack of at least one sufficiently powered randomized multicenter trial to estimate outcomes of emergency CABG with MECC and CECC. The mechanism why MECC might be associated with reduced mortality is still speculative and ranges from improved myocardial protection through consequent use of blood cardioplegia, reduced transfusion requirement, less pronounced inflammatory response, to selection of healthier patients. Critics of minimized ECC also may question whether small clinical effects justify a more complex procedure with learning curves and more intense and challenging interplay between surgeon, anesthesiologist and perfusionist.
The unadjusted 30-day mortality, particularly in the CECC group appears quite high. However, other studies also report data of approximately 10% and 11.4% and thus our reported total mortality of 11.8% is in line with these reports, but offers room for improvement. Since after matching the discrepancy between both groups almost disappeared, it seems that some patients in the CECC group had unmeasured comorbidity that might have contributed to excessive mortality.
The interplay between proper patient selection, pre- and perioperative stabilization including medical treatment and optimal surgical technique remain mandatory to address this high-risk patient group.
Strength and limitations
Findings from propensity score analyses might be potentially limited by biases related to unmeasured and hidden covariates. Since our sensitivity analysis showed low values for Γ for several outcome variables, it is likely that unmeasured covariates contribute to our results and require further research. Incomplete or inexact matching might also affect study results. Our matching efficiency was almost 70% of all MECC patients, but still contrasts other PS studies with matching efficiencies < 50%. On the other hand, those matched were very comparable and enabled direct analysis.
We could not demonstrate significant different treatment effects for patients undergoing emergency revascularization with minimized or conventional extracorporeal circulation. The findings of our study, based on a non-randomized design, are largely hypothesis generating and call for at least one randomized, multicenter trial using a current risk score for precise uniform evaluation of coronary pathology and predefined criteria for perioperative care. Thus, routine MECC use for emergency CABG currently may not be indicated.
Except for the authors there was no person who substantially contributed towards the study or the manuscript. There is no source of funding.
- Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T, Garg S, Huber K, James S, Knuuti J, Lopez-Sendon J, Marco J, Menicanti L, Ostojic M, Piepoli MF, Pirlet C, Pomar JL, Reifart N, Ribichini FL, Schalij MJ, Sergeant P, Serruys PW, Silber S, Sousa Uva M, Taggart D, Vahanian A, Auricchio A, Bax J, Ceconi C, Dean V, Filippatos G, Funck-Brentano C: Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2010, 31: 2501-2555.View ArticlePubMedGoogle Scholar
- Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, Stahle E, Feldman TE, van den Brand M, Bass EJ, Van Dyck N, Leadley K, Dawkins KD, Mohr FW: Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009, 360: 961-972. 10.1056/NEJMoa0804626.View ArticlePubMedGoogle Scholar
- Puehler T, Haneya A, Philipp A, Camboni D, Hirt S, Zink W, Lehle K, Rupprecht L, Kobuch R, Diez C, Schmid C: Minimized extracorporeal circulation in coronary artery bypass surgery is equivalent to standard extracorporeal circulation in patients with reduced left ventricular function. Thorac Cardiovasc Surg. 2010, 58: 204-209. 10.1055/s-0029-1241028.View ArticlePubMedGoogle Scholar
- Mazzei V, Nasso G, Salamone G, Castorino F, Tommasini A, Anselmi A: Prospective randomized comparison of coronary bypass grafting with minimal extracorporeal circulation system (MECC) versus off-pump coronary surgery. Circulation. 2007, 116: 1761-1767. 10.1161/CIRCULATIONAHA.107.697482.View ArticlePubMedGoogle Scholar
- Immer FF, Ackermann A, Gygax E, Stalder M, Englberger L, Eckstein FS, Tevaearai HT, Schmidli J, Carrel TP: Minimal extracorporeal circulation is a promising technique for coronary artery bypass grafting. Ann Thorac Surg. 2007, 84: 1515-1520. 10.1016/j.athoracsur.2007.05.069. discussion 1521View ArticlePubMedGoogle Scholar
- Anastasiadis K, Asteriou C, Deliopoulos A, Argiriadou H, Karapanagiotidis G, Antonitsis P, Grosomanidis V, Misias G, Papakonstantinou C: Haematological effects of minimized compared to conventional extracorporeal circulation after coronary revascularization procedures. Perfusion. 2010, 25: 197-203. 10.1177/0267659110373840.View ArticlePubMedGoogle Scholar
- Wiesenack C, Liebold A, Philipp A, Ritzka M, Koppenberg J, Birnbaum DE, Keyl C: Four years’ experience with a miniaturized extracorporeal circulation system and its influence on clinical outcome. Artif Organs. 2004, 28: 1082-1088. 10.1111/j.1525-1594.2004.00030.x.View ArticlePubMedGoogle Scholar
- Fromes Y, Gaillard D, Ponzio O, Chauffert M, Gerhardt MF, Deleuze P, Bical OM: Reduction of the inflammatory response following coronary bypass grafting with total minimal extracorporeal circulation. Eur J Cardiothorac Surg. 2002, 22: 527-533. 10.1016/S1010-7940(02)00372-X.View ArticlePubMedGoogle Scholar
- Schottler J, Lutter G, Boning A, Soltau D, Bein B, Caliebe D, Haake N, Schoeneich F, Cremer J: Is there really a clinical benefit of using minimized extracorporeal circulation for coronary artery bypass grafting?. Thorac Cardiovasc Surg. 2008, 56: 65-70. 10.1055/s-2007-989336.View ArticlePubMedGoogle Scholar
- Puehler T, Haneya A, Philipp A, Wiebe K, Keyser A, Rupprecht L, Hirt S, Kobuch R, Diez C, Hilker M, Schmid C: Minimal extracorporeal circulation: an alternative for on-pump and off-pump coronary revascularization. Ann Thorac Surg. 2009, 87: 766-772. 10.1016/j.athoracsur.2008.11.050.View ArticlePubMedGoogle Scholar
- Haneya A, Philipp A, Schmid C, Diez C, Kobuch R, Hirt S, Zink W, Puehler T: Minimised versus conventional cardiopulmonary bypass: outcome of high-risk patients. Eur J Cardiothorac Surg. 2009, 36: 844-848. 10.1016/j.ejcts.2009.05.045.View ArticlePubMedGoogle Scholar
- Christiansen S, Autschbach R: Results and treatment strategy for patients undergoing emergent coronary artery bypass grafting. Ann Thorac Cardiovasc Surg. 2010, 16: 168-173.PubMedGoogle Scholar
- Rastan AJ, Eckenstein JI, Hentschel B, Funkat AK, Gummert JF, Doll N, Walther T, Falk V, Mohr FW: Emergency coronary artery bypass graft surgery for acute coronary syndrome: beating heart versus conventional cardioplegic cardiac arrest strategies. Circulation. 2006, 114: I477-I485.View ArticlePubMedGoogle Scholar
- Kerendi F, Puskas JD, Craver JM, Cooper WA, Jones EL, Lattouf OM, Vega JD, Guyton RA: Emergency coronary artery bypass grafting can be performed safely without cardiopulmonary bypass in selected patients. Ann Thorac Surg. 2005, 79: 801-806. 10.1016/j.athoracsur.2004.08.010.View ArticlePubMedGoogle Scholar
- Locker C, Mohr R, Paz Y, Kramer A, Lev-Ran O, Pevni D, Shapira I: Myocardial revascularization for acute myocardial infarction: benefits and drawbacks of avoiding cardiopulmonary bypass. Ann Thorac Surg. 2003, 76: 771-776. 10.1016/S0003-4975(03)00732-X. discussion 776–7View ArticlePubMedGoogle Scholar
- Roques F, Michel P, Goldstone AR, Nashef SA: The logistic EuroSCORE. Eur Heart J. 2003, 24: 881-882. 10.1016/S0195-668X(02)00801-1.View ArticlePubMedGoogle Scholar
- Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R: European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg. 1999, 16: 9-13. 10.1016/S1010-7940(99)00134-7.View ArticlePubMedGoogle Scholar
- National Kidney F: K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002, 39: S1-S266.Google Scholar
- PSMATCH2: Stata module to perform full Mahalanobis and prpoensity score matching, common support graphing and covariate imbalance testing.http://ideas.repec.org/c/boc/bocode/S432001.html,
- RBOUNDS: Stata module to perform Rosenbaum sensitivity analysis for average treatment effects on the treated.http://ideas.repec.org/c/boc/bocode/s438301.html,
- White HD, Assmann SF, Sanborn TA, Jacobs AK, Webb JG, Sleeper LA, Wong CK, Stewart JT, Aylward PE, Wong SC, Hochman JS: Comparison of percutaneous coronary intervention and coronary artery bypass grafting after acute myocardial infarction complicated by cardiogenic shock: results from the Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK) trial. Circulation. 2005, 112: 1992-2001. 10.1161/CIRCULATIONAHA.105.540948.View ArticlePubMedGoogle Scholar
- Danner BC, Didilis VN, Stojanovic T, Popov A, Grossmann M, Seipelt R, Schondube FA: A three-group model to predict mortality in emergent coronary artery bypass graft surgery. Ann Thorac Surg. 2009, 88: 1433-1439. 10.1016/j.athoracsur.2009.06.059.View ArticlePubMedGoogle Scholar
- Darwazah AK, Sham’a RA, Isleem I, Hanbali B, Jaber B: Off-pump coronary artery bypass for emergency myocardial revascularization. Asian Cardiovasc Thorac Ann. 2009, 17: 133-138.View ArticlePubMedGoogle Scholar
- Stamou SC, Hill PC, Haile E, Prince S, Mack MJ, Corso PJ: Clinical outcomes of nonelective coronary revascularization with and without cardiopulmonary bypass. J Thorac Cardiovasc Surg. 2006, 131: 28-33. 10.1016/j.jtcvs.2005.08.059.View ArticlePubMedGoogle Scholar
- D’Agostino RB: Propensity scores in cardiovascular research. Circulation. 2007, 115: 2340-2343. 10.1161/CIRCULATIONAHA.105.594952.View ArticlePubMedGoogle Scholar
- Austin PC: Propensity-score matching in the cardiovascular surgery literature from 2004 to 2006: a systematic review and suggestions for improvement. J Thorac Cardiovasc Surg. 2007, 134: 1128-1135. 10.1016/j.jtcvs.2007.07.021.View ArticlePubMedGoogle Scholar
- Biancari F, Rimpilainen R: Meta-analysis of randomised trials comparing the effectiveness of miniaturised versus conventional cardiopulmonary bypass in adult cardiac surgery. Heart. 2009, 95: 964-969. 10.1136/hrt.2008.158709.View ArticlePubMedGoogle Scholar
- Benedetto U, Angeloni E, Refice S, Capuano F, Goracci M, Roscitano A, Sinatra R: Is minimized extracorporeal circulation effective to reduce the need for red blood cell transfusion in coronary artery bypass grafting? Meta-analysis of randomized controlled trials. J Thorac Cardiovasc Surg. 2009, 138: 1450-1453. 10.1016/j.jtcvs.2009.03.042.View ArticlePubMedGoogle Scholar
- Sezai A, Hata M, Yoshitake I, Kimura H, Takahashi K, Hata H, Shiono M: Results of emergency coronary artery bypass grafting for acute myocardial infarction: importance of intraoperative and postoperative cardiac medical therapy. Ann Thorac Cardiovasc Surg. 2012, 18: 338-346. 10.5761/atcs.oa.11.01821.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.